On Friday, Sarepta Therapeutics Inc (NASDAQ: SRPT) opened lower -2.14% from the last session, before settling in for the closing price of $61.76. Price fluctuations for SRPT have ranged from $48.01 to $173.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 38.19% over the past five years. Company’s average yearly earnings per share was noted 70.20% at the time writing. With a float of $91.14 million, this company’s outstanding shares have now reached $96.90 million.
Let’s look at the performance matrix of the company that is accounted for 1372 employees. In terms of profitability, gross margin is 82.76%, operating margin of 11.47%, and the pretax margin is 13.71%.
Sarepta Therapeutics Inc (SRPT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sarepta Therapeutics Inc is 6.07%, while institutional ownership is 91.99%. The most recent insider transaction that took place on Mar 12 ’25, was worth 248,203. In this transaction Director of this company sold 2,491 shares at a rate of $99.64, taking the stock ownership to the 27,812 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Director proposed sale 2,491 for $99.65, making the entire transaction worth $248,226.
Sarepta Therapeutics Inc (SRPT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 70.20% per share during the next fiscal year.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Trading Performance Indicators
Check out the current performance indicators for Sarepta Therapeutics Inc (SRPT). In the past quarter, the stock posted a quick ratio of 3.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.38, a number that is poised to hit -3.21 in the next quarter and is forecasted to reach 12.56 in one year’s time.
Technical Analysis of Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc (NASDAQ: SRPT) saw its 5-day average volume 1.76 million, a positive change from its year-to-date volume of 1.71 million. As of the previous 9 days, the stock’s Stochastic %D was 82.66%. Additionally, its Average True Range was 4.14.
During the past 100 days, Sarepta Therapeutics Inc’s (SRPT) raw stochastic average was set at 13.69%, which indicates a significant decrease from 84.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.65% in the past 14 days, which was higher than the 72.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.60, while its 200-day Moving Average is $115.49. Nevertheless, the first resistance level for the watch stands at $61.59 in the near term. At $62.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $63.55. If the price goes on to break the first support level at $59.63, it is likely to go to the next support level at $58.81. Assuming the price breaks the second support level, the third support level stands at $57.66.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Key Stats
There are currently 97,032K shares outstanding in the company with a market cap of 5.86 billion. Presently, the company’s annual sales total 1,902 M according to its annual income of 235,240 K. Last quarter, the company’s sales amounted to 658,410 K and its income totaled 159,050 K.
